The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
Structure-activity relationships (SAR) and mechanistic analysis of clinical-stage anti-cancer small molecule ONC201 analogues.
 
Jessica Wagner
No Relationships to Disclose
 
Gary Olson
Employment - Proaid Pharma
Leadership - Provid Pharma
 
Bhaskara Rao Nallaganchu
Employment - Provid Pharma
 
Richard Pottorf
Employment - Provid Pharma
 
Martin Stogniew
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
 
Lee Schalop
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
 
Wolfgang Oster
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
 
Mathew Garnett
No Relationships to Disclose
 
Ultan McDermott
No Relationships to Disclose
 
Cyril Benes
Speakers' Bureau - AstraZeneca
Research Funding - Amgen; Novartis
 
Rohinton Tarapore
No Relationships to Disclose
 
Joshua E. Allen
Employment - Oncoceutics
Leadership - Oncoceutics
Stock and Other Ownership Interests - Oncoceutics
Patents, Royalties, Other Intellectual Property - Oncoceutics
 
Wafik S. El-Deiry
Stock and Other Ownership Interests - Oncoceutics; p53-Therapeutics
Consulting or Advisory Role - Morphotek
Patents, Royalties, Other Intellectual Property - I hold patents and have submitted patents relevant to my academic laboratory research. However, these patent have no relationship with my GI ASCO presentation.